Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Thoma Bravo to take HR software provider Dayforce private

Reuters on MSN · 3d
Dayforce to go private in $12.3 billion Thoma Bravo acquisition
Private equity firm Thoma Bravo has agreed to buy human resources software provider Dayforce for $12.3 billion, including debt, in a take-private deal that executives hope will help expand on the company's AI capabilities.
MarketWatch on MSN · 4d
Dayforce’s stock wasn’t getting enough love, so Thoma Bravo stepped in with $12 billion
The $12 billion take-private deal of the human-resources software company comes after the stock had already lost more than a quarter of its value this year.
Insider Monkey on MSN · 7h
Dayforce (DAYS) Climbs 31% on $12.3-Billion Thoma Bravo Merger
Under the tender offer agreement, Thoma Bravo will acquire all shares of Dayforce Inc. (NYSE:DAY) at a price of $70.
Security Info Watch
27m

Verint to be Acquired by Thoma Bravo in $2B All-Cash Deal

Verint will be combined with Calabrio, another customer experience technology company in Thoma Bravo’s portfolio.
6d

Private Equity Powerhouse Eyes Dayforce in Billion-Dollar Deal

Private equity giant Thoma Bravo is reportedly circling Dayforce, a $1.76B cloud HCM leader, in what could be a landmark deal ...
3don MSN

Goldman Sachs pledges $6B debt package for Thoma Bravo's Dayforce takeover - report

Goldman Sachs (NYSE:GS) has lined up a $6B debt financing package to back private equity firm Thoma Bravo's acquisition of HR ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy